CSL (ASX:CSL; USOTC:CSLLY), a global biopharma leader, today broke ground for the expansion of its state-of-the-art ...
Abstract: The global food industry prioritizes the quality and safety of fish and seafood products due to their perishable nature and the increasing consumer demand for nutritious, high-quality ...
Abstract: The COVID-19 pandemic significantly disrupted higher education, forcing a rapid shift to remote learning and profoundly impacting teaching and learning environments. This study evaluates the ...
Share price volatility is prompting companies to refine their investor communications and leading some to take a more ...
After three decades of investing, Reece Birtles has developed a sixth sense for detecting a big market event – he reads the tension in his body. As head of Australian equities at ClearBridge ...
CSL granted Eli Lilly certain rights for clazakizumab CSl to receive upfront payment of $100 million CSL shares up 2.1% CSL will retain exclusive rights to develop and commercialise clazakizumab for ...
Under terms of the allocation deal, Carlisle Development Parters will pay $14 million over the next five years for the right ...
This high-performance driving feature showcases the raw power and lightweight engineering of the BMW M4 CSL during a high-speed run in Germany. The evaluation focuses on the car's 550-horsepower ...
Super Micro Computer (SMCI) dropped 11% this week despite crushing earnings on February 3rd. Wall Street focused this week on margin pressures, which led to more pressure on shares. Goldman Sachs ...
All hope might not be lost with this fallen angel. It's not hard to see why. CSL reported revenues of US$8.3 billion, a drop of 4% over the same period last year. Reported net profits after tax (NPAT) ...
One day after CSL suddenly replaced its CEO, the company provided dismal financial figures that helped explain why. In its half-year report, CSL said its net profit plummeted (PDF) from $2 billion in ...
SYDNEY--Shares of pharmaceutical company CSL fell early Wednesday as investors react to the sudden departure of chief executive Paul McKenzie and an 80% fall in first-half net profit. The stock was ...